Showing results (231-240 of 782) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|December 4, 2016
Assisted partner services for HIV in Kenya: a cluster randomised controlled trialPeter Cherutich, Matthew R Golden, Beatrice Wamuti, et al.
The Lancet. HIV|December 5, 2016
Transmission networks and risk of HIV infection in KwaZulu-Natal, South Africa: a community-wide phylogenetic studyTulio de Oliveira, Ayesha B M Kharsany, Tiago Gräf, et al.
The Lancet. HIV|November 6, 2016
Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE studyMark A Boyd, Janaki Amin, Patrick W G Mallon, et al.
The Lancet. HIV|November 20, 2016
Swaziland HIV Incidence Measurement Survey (SHIMS): a prospective national cohort studyJessica Justman, Jason B Reed, George Bicego, et al.
The Lancet. HIV|February 4, 2017
From HIV infection to therapeutic response: a population-based longitudinal HIV cascade-of-care study in KwaZulu-Natal, South AfricaNoah Haber, Frank Tanser, Jacob Bor, et al.
The Lancet. HIV|September 10, 2022
Alignment of PrEP adherence with periods of HIV risk among adolescent girls and young women in South Africa and Zimbabwe: a secondary analysis of the HPTN 082 randomised controlled trialJennifer Velloza, Deborah Donnell, Sybil Hosek, et al.
The Lancet. HIV|September 2, 2022
A community mobilisation intervention to improve engagement in HIV testing, linkage to care, and retention in care in South Africa: a cluster-randomised controlled trialSheri A Lippman, Audrey Pettifor, Mi-Suk Kang Dufour, et al.
The Lancet. HIV|September 2, 2022
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trialPauline Amuge, Abbas Lugemwa, Ben Wynne, et al.
The Lancet. HIV|September 8, 2022
HIV incidence estimation among female sex workers in South Africa: a multiple methods analysis of cross-sectional survey dataReshma Kassanjee, Alex Welte, Kennedy Otwombe, et al.
The Lancet. HIV|August 3, 2019
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy studyBeatriz Grinsztejn, Michael D Hughes, Justin Ritz, et al.
Pageof 79